EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for AQST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2026 -0.603
December 31, 2025 -0.7774
September 30, 2025 -0.7032
June 30, 2025 -0.6899
March 31, 2025 -0.5837
December 31, 2024 -0.5179
September 30, 2024 -0.4493
June 30, 2024 -0.3544
March 31, 2024 -0.4252
December 31, 2023 -0.1416
September 30, 2023 -0.2503
June 30, 2023 -0.4534
March 31, 2023 -0.711
December 31, 2022 -1.139
September 30, 2022 -1.629
June 30, 2022 -1.765
March 31, 2022 -1.740
December 31, 2021 -1.834
September 30, 2021 -1.720
Date Value
June 30, 2021 -1.841
March 31, 2021 -1.577
December 31, 2020 -1.656
September 30, 2020 -1.532
June 30, 2020 -1.776
March 31, 2020 -2.526
December 31, 2019 -2.623
September 30, 2019 -2.704
June 30, 2019 -2.604
March 31, 2019 -3.235
December 31, 2018 -2.482
September 30, 2018 -2.346
June 30, 2018 -1.400
March 31, 2018 -0.2088
December 31, 2017 -0.4538
September 30, 2017 -0.0301
June 30, 2017 -0.3409
March 31, 2017 -0.0822

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Nektar Therapeutics -8.420
Crinetics Pharmaceuticals, Inc. -5.133
Talphera, Inc. -0.3009
Aytu Biopharma, Inc. -4.584
Journey Medical Corp. -0.3834